Related Experiment Video
Updated: Jun 20, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomaviruses and the interferon response
Melanie Beglin1, Marta Melar-New, Laimonis Laimins
1Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Abstract:
Human papillomaviruses (HPV) are small DNA viruses that target stratified keratinocytes for infection. A subset of HPV types infect epithelia in the genital tract and are the causative agents of cervical as well as other anogenital cancers. Interferon treatment of existing genital HPV lesions has had mixed results. While HPV proteins down-regulate the expression of interferon-inducible genes, interferon treatment ultimately induces their high-level transcription after a delay. Cells containing complete HPV genomes that are able to undergo productive replication upon differentiation are sensitive to interferon-induced growth arrest, while cells from high-grade cancers that only express E6 and E7 are resistant. Recent studies indicate this sensitivity is dependent upon the binding of the interferon-inducible factor, p56, to the E1 replication protein. The response to interferon by HPV proteins is complex and results from the action of multiple viral proteins.
Insights
Human papillomaviruses (HPV) can cause anogenital cancers. Interferon treatment shows complex effects, with some HPV-infected cells sensitive to growth arrest via p56 binding to the E1 protein.
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Human papillomaviruses (HPV) are DNA viruses infecting keratinocytes, with certain types causing anogenital cancers.
- Interferon treatment for HPV lesions yields variable outcomes.
- HPV proteins interfere with interferon-inducible gene expression.
Purpose of the Study:
- To investigate the complex interplay between interferon treatment and human papillomaviruses.
- To elucidate the mechanisms underlying differential cellular responses to interferon in HPV infections.
Main Methods:
- Analysis of interferon's effect on HPV-infected cells with complete genomes versus those expressing only E6/E7.
- Examination of the role of the interferon-inducible factor p56 and its interaction with the HPV E1 replication protein.
Main Results:
- Cells with complete HPV genomes are sensitive to interferon-induced growth arrest, unlike high-grade cancer cells expressing only E6/E7.
- Sensitivity to interferon-induced growth arrest is linked to p56 binding to the HPV E1 replication protein.
- Multiple viral proteins contribute to the complex response of HPV to interferon.
Conclusions:
- The cellular response to interferon in HPV infections is multifaceted, involving viral protein interactions.
- Targeting the p56-E1 interaction may offer therapeutic avenues for HPV-related cancers.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes
Mechanisms of Retrovirus-induced Cancers

